MEYER HANDELMAN CO

Position in ELTX — Elicio Therapeutics, Inc.

CIK 45319 RYE BROOK, NY

Position in ELTX

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$54,345

-$94,235 QoQ

Shares Held

13,899

0.0% QoQ

Ownership

0.053%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#20

of 48 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MEYER HANDELMAN CO holds $2,456,654 across 4 Biotechnology names. ELTX ranks #4 (2.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	2,609	$1,626,815
2	LBRX	Lb Pharmaceuticals Inc	15,094	$489,875
3	VRTX	Vertex Pharmaceuticals Inc / Ma	575	$285,619
4	ELTX	Elicio Therapeutics, Inc. This page	13,899	$54,345

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$54,345	13,899	0.0%	Shares	Sole	2026-08-03
2026-03-31	$148,580	13,899	0.0%	Shares	Sole	2026-04-20
2025-12-31	$110,636	13,899	0.0%	Shares	Sole	2026-01-15
2025-09-30	$152,055	13,899	0.0%	Shares	Sole	2025-10-16
2025-06-30	$107,300	13,899	0.0%	Shares	Sole	2025-07-16
2025-03-31	$85,617	13,899	0.0%	Shares	Sole	2025-04-08
2024-12-31	$70,884	13,899	0.0%	Shares	Sole	2025-01-14
2024-09-30	$69,911	13,899	0.0%	Shares	Sole	2024-10-10
2024-06-30	$57,124	13,899	0.0%	Shares	Sole	2024-07-16
2024-03-31	$105,632	13,899	0.0%	Shares	Sole	2024-04-11
2023-12-31	$115,917	13,899	0.0%	Shares	Sole	2024-01-17
2023-09-30	$117,446	13,899	+5.0%	Shares	Sole	2023-11-06
2023-06-30	$125,761	13,238	—	Shares	Sole	2023-07-21
No filing history on record for this holder in this stock.